Literature DB >> 16622000

Antigen-induced IL-10+ regulatory T cells are independent of CD25+ regulatory cells for their growth, differentiation, and function.

Kirsty S Nicolson1, Emma J O'Neill, Anette Sundstedt, Heather B Streeter, Sophie Minaee, David C Wraith.   

Abstract

Recent studies have emphasized the importance of T cells with regulatory/suppressor properties in controlling autoimmune diseases. A number of different types of regulatory T cells have been described with the best characterized being the CD25(+) population. In addition, it has been shown that regulatory T cells can be induced by specific Ag administration. In this study, we investigate the relationship between peptide-induced, CD4(+) regulatory T cells and naturally occurring CD4(+)CD25(+) cells derived from the Tg4 TCR-transgenic mouse. Peptide-induced cells were FoxP3(-) and responded to Ag by secreting IL-10, whereas CD25(+) cells failed to secrete this cytokine. Both cell types were able to suppress the proliferation of naive lymphocytes in vitro although with distinct activation sensitivities. Depletion of CD25(+) cells did not affect the suppressive properties of peptide-induced regulators. Furthermore, peptide-induced regulatory/suppressor T cells could be generated in RAG(-/-), TCR-transgenic mice that do not spontaneously generate CD25(+) regulatory cells. These results demonstrate that these natural and induced regulatory cells fall into distinct subsets.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16622000      PMCID: PMC2629539          DOI: 10.4049/jimmunol.176.9.5329

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  52 in total

1.  Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific.

Authors:  A M Thornton; E M Shevach
Journal:  J Immunol       Date:  2000-01-01       Impact factor: 5.422

2.  IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo.

Authors:  M Hara; C I Kingsley; M Niimi; S Read; S E Turvey; A R Bushell; P J Morris; F Powrie; K J Wood
Journal:  J Immunol       Date:  2001-03-15       Impact factor: 5.422

Review 3.  A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3.

Authors:  Jason D Fontenot; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2005-04       Impact factor: 25.606

4.  Differential cytokine requirements for regulation of autoimmune gastritis and colitis by CD4(+)CD25(+) T cells.

Authors:  E Suri-Payer; H Cantor
Journal:  J Autoimmun       Date:  2001-03       Impact factor: 7.094

5.  Human anergic/suppressive CD4(+)CD25(+) T cells: a highly differentiated and apoptosis-prone population.

Authors:  L S Taams; J Smith; M H Rustin; M Salmon; L W Poulter; A N Akbar
Journal:  Eur J Immunol       Date:  2001-04       Impact factor: 5.532

6.  Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells.

Authors:  H Jonuleit; E Schmitt; G Schuler; J Knop; A H Enk
Journal:  J Exp Med       Date:  2000-11-06       Impact factor: 14.307

Review 7.  Differentiation of T regulatory cells by immature dendritic cells.

Authors:  M G Roncarolo; M K Levings; C Traversari
Journal:  J Exp Med       Date:  2001-01-15       Impact factor: 14.307

8.  Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood.

Authors:  D Dieckmann; H Plottner; S Berchtold; T Berger; G Schuler
Journal:  J Exp Med       Date:  2001-06-04       Impact factor: 14.307

9.  Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood.

Authors:  H Jonuleit; E Schmitt; M Stassen; A Tuettenberg; J Knop; A H Enk
Journal:  J Exp Med       Date:  2001-06-04       Impact factor: 14.307

10.  Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells.

Authors:  M V Dhodapkar; R M Steinman; J Krasovsky; C Munz; N Bhardwaj
Journal:  J Exp Med       Date:  2001-01-15       Impact factor: 14.307

View more
  19 in total

Review 1.  Control of experimental autoimmune encephalomyelitis by CD4+ suppressor T cells: peripheral versus in situ immunoregulation.

Authors:  Margaret S Bynoe; Paula Bonorino; Christophe Viret
Journal:  J Neuroimmunol       Date:  2007-09-27       Impact factor: 3.478

2.  Antigenic strength controls the generation of antigen-specific IL-10-secreting T regulatory cells.

Authors:  Leona Gabrysová; David C Wraith
Journal:  Eur J Immunol       Date:  2010-05       Impact factor: 5.532

Review 3.  Therapeutic peptide vaccines for treatment of autoimmune diseases.

Authors:  David C Wraith
Journal:  Immunol Lett       Date:  2008-12-25       Impact factor: 3.685

4.  Therapeutic vaccination with a trivalent T-cell receptor (TCR) peptide vaccine restores deficient FoxP3 expression and TCR recognition in subjects with multiple sclerosis.

Authors:  Arthur A Vandenbark; Nicole E Culbertson; Richard M Bartholomew; Jianya Huan; Marci Agotsch; Dorian LaTocha; Vijayshree Yadav; Michele Mass; Ruth Whitham; Jesus Lovera; June Milano; Georgia Theofan; Yuan K Chou; Halina Offner; Dennis N Bourdette
Journal:  Immunology       Date:  2007-10-16       Impact factor: 7.397

5.  Involvement of Foxp3-expressing CD4+ CD25+ regulatory T cells in the development of tolerance induced by transforming growth factor-beta2-treated antigen-presenting cells.

Authors:  Haining Zhang; Peizeng Yang; Hongyan Zhou; Qianli Meng; Xiangkun Huang
Journal:  Immunology       Date:  2008-02-11       Impact factor: 7.397

6.  Isolation and characterization of human interleukin-10-secreting T cells from peripheral blood.

Authors:  Graziella Mazza; Catherine A Sabatos-Peyton; Rachel E Protheroe; Andrew Herman; John D Campbell; David C Wraith
Journal:  Hum Immunol       Date:  2010-01-07       Impact factor: 2.850

7.  Enhanced selection of FoxP3+ T-regulatory cells protects CTLA-4-deficient mice from CNS autoimmune disease.

Authors:  Johan Verhagen; Leona Gabrysová; Sophie Minaee; Catherine A Sabatos; Graham Anderson; Arlene H Sharpe; David C Wraith
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-13       Impact factor: 11.205

Review 8.  Adaptive immune responses in CNS autoimmune disease: mechanisms and therapeutic opportunities.

Authors:  Rhoanne C McPherson; Stephen M Anderton
Journal:  J Neuroimmune Pharmacol       Date:  2013-04-09       Impact factor: 4.147

9.  Negative feedback control of the autoimmune response through antigen-induced differentiation of IL-10-secreting Th1 cells.

Authors:  Leona Gabrysová; Kirsty S Nicolson; Heather B Streeter; Johan Verhagen; Catherine A Sabatos-Peyton; David J Morgan; David C Wraith
Journal:  J Exp Med       Date:  2009-07-27       Impact factor: 14.307

10.  Foxp3+ regulatory T cells are required for recovery from severe sepsis.

Authors:  Franziska Kühlhorn; Matthias Rath; Katrin Schmoeckel; Katharina Cziupka; Huu Hung Nguyen; Petra Hildebrandt; Thomas Hünig; Tim Sparwasser; Jochen Huehn; Christian Pötschke; Barbara M Bröker
Journal:  PLoS One       Date:  2013-05-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.